Point of Care Diagnostics - APAC Analysis and Market Forecasts
The Asia-Pacific (APAC) Point-Of-Care (POC) diagnostics market is a dynamic market that is expected to grow through 2021. The driving concept in sustenance of POC testing is to bring testing nearer to the patient and results swiftly to the physician to accelerate diagnosis and subsequent treatment. POC testing allows for faster clinical decisions in emergency departments, physicians’ offices, ambulances, patient homes, and in the field. Because of its convenience, and potential to reduce hospital time stay, testing at POC has risen in popularity in recent years in APAC countries.
A number of factors, such as such as the increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home-based POC devices, expansion of test menu, and technological advancements in molecular testing and lab-on-chip technology are stimulating the demand for POC testing. While POC testing is one of the most active segments within the in-vitro diagnostics (IVD) industry, the rate of POC testing adoption will be moderated by the requirement for regulatory compliance, the pressure to control cost, and the need to demonstrate clear clinical-cost benefits of POC testing over central laboratory testing. Moving forward, in light of increasing demand for POC testing, manufacturing companies are racing to make the next-generation POC platforms faster, easier, and more reliable.
The POC diagnostics market in the APAC region is determined for three major APAC markets: Japan, China, and India. This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the APAC region. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions in using and evaluating the adoption of different types of POC devices.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
Key Questions Answered
- What is the current and future POC diagnostics market outlook in the APAC region? What trends are affecting the APAC market? - What is the competitive landscape and market share of major players in the POC space in the APAC region? - What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest? - What are the unmet needs with the POC tests currently on the market? How will emerging technologies such as molecular POC assays fulfill these unmet needs? - What are the key factors influencing a physician to use POC tests? What is physician perception and market outlook of POC devices? - What are the challenges and barriers that have hindered widespread adoption of POC devices?
Reasons to buy
- “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Our reports have been used by over 10K customers, including:
200 pages •
By Global Industry Analysts
• Aug 2018
This report analyzes the worldwide markets for Cardiac Biomarkers in US$ Thousand by the following Testing Locations: Laboratory Testing, and Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates...
265 pages •
By Global Industry Analysts
• Jan 2018
This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates...
Report Synopsis Global Biosensors market is expected to record a robust CAGR of about 9% during the 2017-2022 analysis period and is projected to touch US$25.9 billion by 2022 from an estimated US$16.9 billion in 2017. Electrochemical estimated the largest global Biosensors market by technology with 2017 market stood at US$12 billion...
Asia-Pacific IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal...
Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market,...
176 pages •
By Transparency Market Research
• Dec 2016
Global Point-of-Diagnostics Market: Overview Point-of-care diagnostics is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate a prompt clinical decision regarding patient management. The report on point-of-care diagnostic market, analyzes the current and future...